Pfizer PFE1.60%increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So ...

Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know. Pfizer beat analysts’ revenue expectations by 3% last ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

Thousands of Pfizer PFE0.74%increase; green up pointing triangle employees from around the world were watching through their computer screens in October when Chief Executive Albert Bourla and ...

Pfizer (PFE) reported mixed first quarter earnings Tuesday, as the company focuses on gaining investor interest in its near-term pipeline amid a volatile macro environment in the markets. Pfizer ...

Matthew Herper covers medical innovation — both its promise and its perils. Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron ...

You can reach Allison on Signal at AllisonDeAngelis.01. NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of the company — said ...

The claim: Pfizer was sued for $2.3 billion for 'bribing doctors and suppressing adverse trial results' A viral social media post suggests that Americans shouldn't trust Pfizer – one of the ...